Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

PHARMIS BIOFARMACÊUTICA LDA

NIF 502595442
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €6,278,959 76 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €6,278,959 76 contracts
A2 · Late Publication €1,683,385,824 954 contracts
Contract published to BASE more than 10 days after the signing date
LOW €1,683,385,824 954 contracts
A5 · Threshold Splitting €1,369,933 22 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €1,369,933 22 contracts
A6 · Low Competition €3,908,346 11 contracts
Only one bidder participated in a competitive procedure
MEDIUM €3,908,346 11 contracts
A9 · Abnormal Price Reduction €2,325,174,484 646 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €2,325,174,484 646 contracts
B5 · Benford's Law Deviation €1,504,569 1 contracts
Entity's contract values deviate from the Benford leading-digit distribution (chi-square goodness-of-fit, min 20 contracts). Score: 35 (p<0.05) or 55 (p<0.01).
MEDIUM €1,504,569 1 contracts
C3 · Missing Mandatory Fields €284,010 30 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €284,010 30 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

88
€102,953,908
20
€89,127,638
51
€84,706,288
47
€81,879,521
24
€80,369,049
69
€80,289,421
14
€79,798,701
17
€79,577,513
27
€79,383,766
14
€79,194,354
17
€78,463,561
5
€78,278,176
15
€78,153,221
18
€77,934,042
10
€77,807,670
21
€77,050,117
13
€73,989,900
56
€73,539,274
21
€73,406,069
6
€73,257,190
Page 1 of 4 · 62 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Abnormal Price Reduction B5 · Benford's Law Deviation C3 · Missing Mandatory Fields

Page 1 of 1 · 22 contracts

MEDICAMENTOS
PT · 11313299 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication +1
€19,131 2025-02-21
61/1185/2025 - Medicamento Octreotido 0.1 mg/1 ml Sol inj Fr 1 ml IV SC
PT · 11221383 · Ajuste Direto Regime G...
A5 · Threshold Splitting A2 · Late Publication
€4,765 2025-01-30
VÁRIOS MEDICAMENTOS
PT · 11191927 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€71,862 2025-01-20
BEAD20240305 - AQUISIÇÃO DE ANESTESICOS LOCAIS - 2º SEMESTRE
PT · 10903530 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€19,535 2024-09-05
Medicamentos do Aparelho Locomotor 2
PT · 11849550 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting C3 · Missing Mandatory Fields
€74,801 2024-02-26
Aquisição de TETRABENAZINA ORAL 25 MG COMP ao abrigo do CPA 2022/19 para o HFF para o ano 2023
PT · 10227162 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€4,760 2023-09-05
DS_06/01524.11/2022 - Aquisição de "Hidrocortisona 100 mg pó sol inj Fr IM IV ao abrigo do Acordo Quadro nº 2021/47
PT · 9189170 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€144,430 2022-04-08
Medicamentos Anestésicos e Relaxantes Musculares
PT · 9205917 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€71,636 2022-04-08
LIDOCAINA 2% C/ CLOROHEXIDINA 11ML SERINGA
PT · 9185844 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€19,711 2022-04-01
1100016/2022 DM de Proteção
PT · 8903991 · Concurso público
A5 · Threshold Splitting A2 · Late Publication +1
€149,281 2021-12-27
AQUISIÇÃO DE MEDICAMENTOS DO APARELHO LOCOMOTOR, USADOS NAS DOENÇAS ENDÓCRINAS E HORMONAS, AO ABRIGO DO ACORDO QUADRO 2021/047 DOS SPMS, EPE
PT · 9325020 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€74,554 2021-11-16
Q1/2462/2021-Medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas
PT · 7814145 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€145,203 2021-08-11
LIDOCAINA 20 MG/G + CLOROHEXIDINA 0,5 MG
PT · 7689171 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€19,325 2021-05-27
Aquisição de medicamentos
PT · 8353666 · Concurso público
A5 · Threshold Splitting A2 · Late Publication +1
€72,431 2020-03-25
MEDICAMENTOS
PT · 4918944 · Ajuste Direto Regime G...
A5 · Threshold Splitting A9 · Abnormal Price Reduction
€19,704 2018-10-25
Hormonas e Outros Medicamentos Doenças Endocrinas para a ULSNA , EPE em 2017
PT · 3908066 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€71,663 2017-07-25
Fornecimento de hormonas e outros medicamentos usados no tratamento de doenças endocrinas ao abrigo do CPA 2015/007
PT · 4424422 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€74,488 2017-06-16
HIPOTALAMO E HIPOFISE
PT · 3168071 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication +1
€19,283 2017-03-07
MEDICAMENTOS USADOS DOENÇAS ENDÓCRINAS
PT · 2955066 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting
€71,820 2017-01-19
51000117 - MEDICAMENTOS COM CHNM
PT · 4070552 · Ajuste Direto Regime G...
A5 · Threshold Splitting A1 · Repeat Direct Award +2
€74,123 2017-01-16
510408/16 - Aquisição de Melfalano 2 mg comp.
PT · 2476401 · Ao abrigo de acordo-qu...
A5 · Threshold Splitting A2 · Late Publication
€4,876 2016-02-12
21/402/2015-medicamento "Octreotido"
PT · 1463855 · Concurso público
A5 · Threshold Splitting A2 · Late Publication
€142,550 2015-02-05
Overview
Total Value Won
€2,340,803,961
Contracts Won
1,280
Score 50065 · CRITICAL RISK
NIF
502595442
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

No director data imported yet.

Director and fiscal identity data for Portuguese companies can be found in the Registo Comercial (publicacoes.mj.pt).

Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned